According to FutureWise analysis, the market for human rotavirus vaccine in 2023 is US$ 7.66 billion, and is expected to reach US$ 12.6 billion by 2031 at a CAGR of 6.42%.
Rotavirus is a diarrhea-causing virus that is very contagious. Prior to the development of a vaccine, the majority of kids had at least one infection with the virus by the time they turned five. Despite how nasty rotavirus infections are, they are frequently treated at home with additional fluids to prevent dehydration. In the hospital, patients with severe dehydration may need to receive fluids intravenously (via a vein). Maintaining proper hygiene is crucial, including routine hand washing. On the other hand, immunisation is the most effective defence against rotavirus infection. Rotavirus infection typically develops two days after virus contact. The first symptoms are fever and vomiting, which are followed by watery diarrhoea that lasts three to seven days. Additionally, the illness may result in stomach ache.
A healthy adult may experience no symptoms at all or very minor ones as a result of rotavirus infection. Up to ten days before to the onset of symptoms as well as after they have subsided, rotavirus can be found in a person's face. During this time, the virus spreads swiftly through hand-to-mouth contact even if the infected person is asymptomatic. Children under the age of five are most frequently affected by severe diarrhoea from rotavirus infections, which can be prevented by the rotavirus vaccine. Immunizations aid in the prevention of severe diarrhoea in both developed and poor nations. Vaccines reduce the likelihood that young children will die from diarrhoea. Infant vaccination reduces disease rates among the elderly and those who have never had any vaccinations. The rotavirus vaccine should be included in national routine vaccination programmes, particularly in regions where the disease is prevalent, the World Health Organization (WHO) urges.
FutureWise Market Research has instantiated a report that provides an intricate analysis of Human Rotavirus Vaccine Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.
According to the research study conducted by FutureWise research analysts, the Human Rotavirus Vaccine Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.